NCT07705113

Brief Summary

The purpose of this study is to evaluate the adaptation and effectiveness of an integrated treatment module, the Depression and Substance Use Disorder Module (D-SUD-M), for male patients experiencing co-occurring depression and substance use disorders in Pakistan. Participants are divided into two groups: an experimental group receiving the structured D-SUD-M intervention-based sessions and a control group receiving standard routine treatment sessions within the rehabilitation center. The primary objective is to evaluate whether the specialized intervention module significantly reduces depressive symptoms and substance use severity compared to routine standard care.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started May 2026

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 10, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Completed
Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 10, 2026

Last Update Submit

July 15, 2026

Conditions

Keywords

DepressionSubstance Use Disorders (SUDs)ComorbidityRehabilitationTreatment Module D-SUD-MPsychological Intervention

Outcome Measures

Primary Outcomes (2)

  • Change in symptoms severity of depression from baseline to post-intervention

    Assessed using the Beck Depression Inventory (BDI-II). The BDI-II is a 21-item self-report scale measuring characteristics and symptoms of depression. Total scores range from 0 to 63, with higher scores indicating a worse outcome (greater depressive symptom severity).

    Baseline to Post-intervention (5months) total weeks(22)

  • Change in Substance Use Disorder Severity from baseline to post-intervention

    Assessed using the Drug Abuse Screening Test (DAST-10). The DAST -10 is a self-report instrument used to evaluate consequences related to drug misuse. Total scores range from 0 to 10, with higher scores indicating a worse outcome (greater severity of substance use-related problems).

    baseline to post-intervention (5months), total weeks (22)

Study Arms (2)

Experimental Group: Treatment Module D-SUD-M

EXPERIMENTAL

Participants in this group will recieve special treatment module D-SUD-M for patients with Depression and Substance Abuse.

Behavioral: Experimental Group: Treatment Module D-SUD-MBehavioral: Control Group

Control Group

ACTIVE COMPARATOR

No exposure of special treatment module will be given to the participants of this group.

Behavioral: Control Group

Interventions

A specialized psychological Intervention based module design for reducing the symptoms and to check the effectiveness of module on patients with depression and substance use disorder. This module is translated and culturally adapted. A manual treatment booklet was written in which eclectic approaches were used like Behaviour therapy, Cognitive behaviour therapy, relapse prevention, group therapy along with activity sheets for each session. 12 intervention based sessions will be given to the participants of this group.

Experimental Group: Treatment Module D-SUD-M
Control GroupBEHAVIORAL

No module based treatment will be given to the participants of this group.

Control GroupExperimental Group: Treatment Module D-SUD-M

Eligibility Criteria

Age17 Years - 56 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Participants identified by the rehabilitation centre
  • Only male participants will be taken,
  • Age range lies between 17 to 56 years,
  • Screening of depression by using the Beck Depression Inventory (BDI-II) and for Substance Use Disorders using Drug Abuse Screening Test (DAST-10),
  • Diagnosed patients based on DSM-5 clinical diagnostic criteria will be taken into study.

You may not qualify if:

  • Diagnosed cases of other psychopathology including bipolar disorder, psychotic depression, and others will not be taken in study,
  • Cases of cognitive impairment linked to physical illness will not be part of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Najjat Trust

Rawalpindi, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

DepressionSubstance-Related Disorders

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are divided into two groups: An experimental group, which receives routine counseling sessions along with this treatment module. A control group, which receives only routine counseling sessions in the rehabilitation center during the same period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 10, 2026

First Posted

July 15, 2026

Study Start

May 2, 2026

Primary Completion

September 30, 2026

Study Completion

September 30, 2026

Last Updated

July 16, 2026

Record last verified: 2026-07

Locations